{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:49:57Z","timestamp":1791326997396,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,9]],"date-time":"2027-09-09T00:00:00Z","timestamp":1820448000000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014426","name":"American Board of Psychiatry and Neurology Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS124656"],"award-info":[{"award-number":["K23NS124656"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS142800"],"award-info":[{"award-number":["R21NS142800"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.seizure.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:12:40Z","timestamp":1788480760000},"page":"168-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Counterintuitive: reducing regression-to-the-mean worsens efficiency in simulated clinical trials"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-2758","authenticated-orcid":false,"given":"Daniel M.","family":"Goldenholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira R.","family":"Goldenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-6289","authenticated-orcid":false,"given":"Rohan","family":"Bhansali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted J.","family":"Kaptchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4803-312X","authenticated-orcid":false,"given":"M. Brandon","family":"Westover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2026.09.002_bib0001","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S1474-4422(12)70177-1","article-title":"Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions","volume":"11","author":"Friedman","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2026.09.002_bib0002","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/epi.17716","article-title":"Increasing challenges to trial recruitment and conduct over time","volume":"64","author":"Kerr","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eplepsyres.2016.02.002","article-title":"Response to placebo in clinical epilepsy trials\u2013old ideas and new insights","volume":"122","author":"Goldenholz","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2026.09.002_bib0004","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1528-1167.2010.02650.x","article-title":"Historical control monotherapy design in the treatment of epilepsy","volume":"51","author":"French","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ana.24470","article-title":"Confusing placebo effect with natural history in epilepsy: a big data approach","volume":"78","author":"Goldenholz","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2026.09.002_bib0006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.seizure.2017.10.016","article-title":"A multi-dataset time-reversal approach to clinical trial placebo response and the relationship to natural variability in epilepsy","volume":"53","author":"Goldenholz","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2026.09.002_bib0007","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/acn3.426","article-title":"Monte Carlo simulations of randomized clinical trials in epilepsy","volume":"4","author":"Goldenholz","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2026.09.002_bib0008","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/acn3.519","article-title":"Is seizure frequency variance a predictable quantity?","volume":"5","author":"Goldenholz","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.seizure.2026.09.002_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.seizure.2026.09.002_bib0010","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/epi.17730","article-title":"Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy","volume":"64","author":"Goldenholz","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0011","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/epi.17471","article-title":"Flexible realistic simulation of seizure occurrence recapitulating statistical properties of seizure diaries","volume":"64","author":"Goldenholz","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0012","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/epi.12894","article-title":"Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: results of a phase III, double-blind, randomized, placebo-controlled trial","volume":"56","author":"Sperling","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0013","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/epi.16609","article-title":"Statistical efficiency of patient data in randomized clinical trials of epilepsy treatments","volume":"61","author":"Romero","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0014","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10957-008-9477-0","article-title":"Isotonic regression under Lipschitz constraint","volume":"141","author":"Yeganova","year":"2009","journal-title":"J Optim Theory Appl"},{"key":"10.1016\/j.seizure.2026.09.002_bib0015","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/epi.70189","article-title":"Patterns of seizure frequency reduction in clinical trial participants with lower baseline seizure frequency","volume":"67","author":"Kerr","year":"2026","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.09.002_bib0016","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1212\/WNL.0000000000001585","article-title":"Time to prerandomization monthly seizure count in perampanel trials: a novel epilepsy endpoint","volume":"84","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2026.09.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050166","article-title":"Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy","volume":"5","author":"Rheims","year":"2008","journal-title":"PLoS Med"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:49:58Z","timestamp":1791323398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":17,"alternative-id":["S1059131126002670"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.09.002","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Counterintuitive: reducing regression-to-the-mean worsens efficiency in simulated clinical trials","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}